Category: New products
-
3-D Printing Lifecycle Shown More Environmentally Friendly
Materials scientists at Michigan Technological University in Houghton found that in a lifecycle analysis of production processes, distributed three-dimensional printing can have a smaller environmental impact than conventional manufacturing. Michigan Tech’s Joshua Pearce and graduate student Megan Kreiger published their findings online in a recent advance issue of the journal ACS Sustainable Chemistry and Engineering. Three-dimensional…
-
Early Clinical Trial Shows RNA Therapy Lowers Cholesterol
A clinical trial by the biopharmaceutical company Alnylam Pharmaceuticals in Cambridge, Massachusetts shows that one dose of a drug made from interfering ribonucleic acid (RNA) cuts LDL, or bad, cholesterol levels more than a placebo. Results of the study, conducted with colleagues from University of Texas-Southwestern in Dallas and medical centers in the U.K., appear…
-
Programming Language Created for Synthetic DNA Chemistry
Computer scientists and systems biologists at University of Washington, California Institute of Technology, and University of California in San Francisco are developing a coding language to enable the programming of synthetic DNA chemical interactions. A report from the team led by Washington computer scientist Georg Seelig appeared yesterday online in the journal Nature Nanotechnology (paid…
-
Small-Scale Ceramics Materials Engineered for Flexibility
Materials scientists at Massachusetts Institute of Technology and Nanyang Technological University in Singapore created a new type of ceramics material with the ability to bend like metal, but retaining its strength. The team from the lab of MIT’s Christopher Schuh published its findings today in the journal Science (paid subscription required). The MIT-Singapore researchers developed…
-
Genetic Solution Identified for Canola Crop Losses
Biologists at University of Calgary in Canada identified a genetic process in plants similar to the oilseed canola that offers a solution to a problem causing large annual losses of this key cash crop. The team lead by Calgary’s Marcus Samuel, with associates from University of Toronto and University of Bordeaux in France, published its…
-
Computer System Built with Carbon Nanotube Circuitry
Engineers at Stanford University in California created a basic computer system of circuits made from carbon nanotubes rather than conventional semiconductors built on silicon. The team led by Stanford electrical engineering professors Subhasish Mitra and H.S. Philip Wong published its findings online today in the journal Nature (paid subscription required). As silicon semiconductors became smaller and packed more…
-
Trial Tests Chemo-Immunotherapy with Pancreatic Cancer
An early-stage clinical trial found a combination of chemotherapy and antibody protein caused some patients with pancreatic cancer to shrink their tumors. The findings of a study by researchers at University of Pennsylvania in Philadelphia and University of Washington in Seattle appear online in the journal Clinical Cancer Research (paid subscription required). Cancer of the…
-
Clinical Trial to Test Engineered Enzyme with Kidney Failure
AM-Pharma, a biopharmaceutical company in Bunnik, the Netherlands, began recruiting volunteers to test an engineered form of the human enzyme alkaline phosphatase to treat acute kidney injury. The clinical trial will test the safety and tolerability of the human recombinant alkaline phosphatase as well as its enzyme-chemical activity in blood serum, an indicator of treatment…
-
Biotech Start-Up Finds STD Treatment in Anti-Cancer Therapy
Researchers with the biotechnology company TherapyX Inc. in Buffalo, New York found a potential treatment for the sexually transmitted disease (STD) gonorrhea in a therapy the company is developing for cancer. The team from TherapyX, a spin-off company of the University at Buffalo medical school, published its findings today online in the Journal of Infectious…
-
Cleveland Clinic Spin-Off Developing Breast Cancer Vaccine
Shield Biotech, a spin-off company from the Cleveland Clinic in Ohio, is creating a vaccine to prevent breast cancer based on research conducted at the clinic’s research institute. Vincent Tuohy, a Cleveland Clinic immunologist, founded the company with the clinic’s commercialization division, and serves as its chief scientist. Tuohy’s research seeks to find a method for protecting…